Ben Cannon is the Co-Founder of Cue Growth Partners, a medical technology and related healthcare services investment firm. Cue Growth has invested as a Co-Lead alongside BioStar Capital in Amplitude Vascular Systems in lithotripsy, serving the peripheral, coronary and carotid indications, and Field Medical in Pulse Field Ablation, serving the ventricular tachycardia and atrial fibrillation ablation markets. As part of those investments, and the evaluation of potential new investments, he works closely with BioStar’s Managing Partners, Directors and other physician and investment professionals. Prior to Co-Founding Cue Growth, he spent 12 years as a key member of several of the largest private investment firms in the United States. Most recently he served as a Principal in Healthcare at a $250 Billion in assets under management firm, focused predominantly on private equity, growth and venture capital. Prior to his investment career, Ben was a Healthcare Analyst on Wall Street. On a personal note, his true joy is his wife and three kids who live in the NYC area. He grew up in the great state of Michigan, where he won a High School Wrestling State Title and then attended Brown University while wrestling on the D-1 Ivy League program.